Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm?

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Ana Margarida Gonçalves Manso

    Autor

  • Ana Marta Matos Silva

    Autor

  • João Fernando Alturas Da Silva

    Autor

  • Carlos Manuel Pires Martins Da Silva

    Autor

Participantes de fora da FMUP

  • Ramos, P
  • Mateus, A
  • Botelho, F
  • Pacheco-Figueiredo, L

Unidades de investigação

Abstract

Introduction: Bladder cancer (BC) is an increasingly frequent malignancy worldwide. Several variant histologies (VH) have been described in BC with a distinct clinical behavior. Objectives: This study aims to assess the prognostic impact of VH in BC, comparing its outcomes to pure urothelial carcinoma PUC in both non-muscle invasive (NMIBC) and muscle-invasive (MIBC) settings. Methods: We included patients with primary BC, comparing those with VH with those with PUC, with an age and sex-matched proportion of 1:3, considering stage at diagnosis, recurrence-free, progression-free, and overall survival (OS). A total of 616 patients were included in the study, (460 UC and 151 VH). Results: After first TURBT, MIBC was present in 99 (64.1%) of patients with VH, and 95 (20.6%) with UC (p<0.001). Concerning NMIBC, we observed higher rates of progression to MIBC amid patients with VH (p=0.009). Nodal involvement (p=0.020) and metastatic disease (p<0.001) were significantly higher within the VH group. A higher OS was observed among patients with NMIBC of PUC (p<0.001). There were no statistically significant differences of metastasis-free survival and OS between VH and UC groups within the MIBC setting. Conclusion: We confirmed that VH presents a more aggressive clinical course compared to PUC. An earlier radical treatment within the NMIBC setting could increase the oncological outcomes of the VH patients. (c) 2024 Elsevier Inc. All rights reserved.

Dados da publicação

ISSN/ISSNe:
1078-1439, 1873-2496

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS  Elsevier Inc.

Tipo:
Article
Páginas:
1611-1618
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 1

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Urinary bladder neoplasms; Variant histology; Cystectomy; Risk stratification

Proyectos asociados

Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023

Platelet-Lymphocyte Ratio: a Potential Predictor for Late Recurrence of Renal Cell Carcinoma

Investigador Principal: João Fernando Alturas da Silva

Estudo Clínico Académico (Renal Carcinoma) . 2023

The predictive value of surgeon's perception during transurethral resection of bladder tumours

Investigador Principal: João Fernando Alturas da Silva

Estudo Clínico Académico (Transurethral) . 2020

Tratamento da Bexiga Hiperativa Idiopática com Toxina Botulínica: Resultados da Prática Clínica e Expectativas das Pacientes

Investigador Principal: Carlos Manuel Pires Martins da Silva

Estudo Clínico Académico (Toxina Botulínica) . 2020

O Papel dos Factores Neurotróficos nas Disfunções Miccionais: Implicações Fisiopatológicas e Clínicas.

Investigador Principal: Carlos Manuel Pires Martins da Silva

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação